Zenas BioPharma, Inc.·4

Feb 11, 4:20 PM ET

Xiao Ting 4

4 · Zenas BioPharma, Inc. · Filed Feb 11, 2025

Insider Transaction Report

Form 4
Period: 2025-02-07
Xiao Ting
Director
Transactions
  • Purchase

    Common Stock

    2025-02-07$7.76/sh+10,000$77,60047,000 total
Footnotes (1)
  • [F1]The price reported is a weighted average price. These shares were purchased in multiple transactions ranging from $7.64 to $7.78, inclusive. The Reporting Person undertakes to provide the Issuer, any security holder of the Issuer or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares purchased at each separate price within the range.

Documents

1 file
  • 4
    tm256174-1_4seq1.xmlPrimary

    OWNERSHIP DOCUMENT